These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 23017582

  • 1. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.
    Kang SU, Lee BS, Lee SH, Baek SJ, Shin YS, Kim CH.
    J Nutr Biochem; 2013 Jun; 24(6):986-99. PubMed ID: 23017582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
    Chang JW, Kang SU, Choi JW, Shin YS, Baek SJ, Lee SH, Kim CH.
    Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
    [Abstract] [Full Text] [Related]

  • 5. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
    Lee SH, Nam HJ, Kang HJ, Kwon HW, Lim YC.
    Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
    [Abstract] [Full Text] [Related]

  • 6. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
    Amin AR, Khuri FR, Chen ZG, Shin DM.
    Cancer Prev Res (Phila); 2009 Jun; 2(6):538-45. PubMed ID: 19470788
    [Abstract] [Full Text] [Related]

  • 7. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
    Amin AR, Wang D, Zhang H, Peng S, Shin HJ, Brandes JC, Tighiouart M, Khuri FR, Chen ZG, Shin DM.
    J Biol Chem; 2010 Nov 05; 285(45):34557-65. PubMed ID: 20826787
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH, Han DW, Hyon SH, Park JC.
    Apoptosis; 2011 Jan 05; 16(1):75-85. PubMed ID: 20963498
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
    Lee JC, Chung LC, Chen YJ, Feng TH, Chen WT, Juang HH.
    Cancer Lett; 2015 May 01; 360(2):310-8. PubMed ID: 25721086
    [Abstract] [Full Text] [Related]

  • 10. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K, Agarwal MK, Mukhtar H, Agarwal ML.
    FASEB J; 2005 May 01; 19(7):789-91. PubMed ID: 15764647
    [Abstract] [Full Text] [Related]

  • 11. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G.
    Lee JH, Jeong YJ, Lee SW, Kim D, Oh SJ, Lim HS, Oh HK, Kim SH, Kim WJ, Jung JY.
    Cancer Lett; 2010 Apr 01; 290(1):68-75. PubMed ID: 19781850
    [Abstract] [Full Text] [Related]

  • 12. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H.
    Oncogene; 2003 Jul 31; 22(31):4851-9. PubMed ID: 12894226
    [Abstract] [Full Text] [Related]

  • 13. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
    Zhang X, Zhang H, Tighiouart M, Lee JE, Shin HJ, Khuri FR, Yang CS, Chen Z', Shin DM.
    Int J Cancer; 2008 Sep 01; 123(5):1005-14. PubMed ID: 18546267
    [Abstract] [Full Text] [Related]

  • 14. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
    Kim IY, Park SY, Kang Y, Thapa D, Choi HG, Kim JA.
    Arch Pharm Res; 2011 Feb 01; 34(2):323-30. PubMed ID: 21380817
    [Abstract] [Full Text] [Related]

  • 15. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS.
    Oncol Rep; 2012 Nov 01; 28(5):1799-807. PubMed ID: 22923287
    [Abstract] [Full Text] [Related]

  • 16. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R, Sasaki K, Yoshida K.
    Toxicol In Vitro; 2009 Aug 01; 23(5):834-9. PubMed ID: 19406223
    [Abstract] [Full Text] [Related]

  • 17. Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin.
    Shin YS, Kang SU, Park JK, Kim YE, Kim YS, Baek SJ, Lee SH, Kim CH.
    Phytomedicine; 2016 Nov 15; 23(12):1344-1355. PubMed ID: 27765354
    [Abstract] [Full Text] [Related]

  • 18. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation.
    Roy AM, Baliga MS, Katiyar SK.
    Mol Cancer Ther; 2005 Jan 15; 4(1):81-90. PubMed ID: 15657356
    [Abstract] [Full Text] [Related]

  • 19. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
    Masuda M, Suzui M, Lim JT, Weinstein IB.
    Clin Cancer Res; 2003 Aug 15; 9(9):3486-91. PubMed ID: 12960141
    [Abstract] [Full Text] [Related]

  • 20. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.
    Liu J, Uematsu H, Tsuchida N, Ikeda MA.
    Mol Cancer; 2011 Jul 31; 10():95. PubMed ID: 21801448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.